Sensus Healthcare appoints Michael Sardano to Board of Directors effective Feb 1, 2024

Sensus Healthcare, Inc.

Michael Sardano, currently President, General Counsel, and Corporate Secretary, appointed as Class II director.
Term expires at the 2026 annual meeting; no committee assignments.
Mr. Sardano is the son of Chairman and CEO Joseph C. Sardano.
No arrangement or understanding with any other person led to the appointment.
He has been employed by the Company since 2013 in various legal and management roles.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Sardano

Director

SRTS · Sensus Healthcare, Inc.

Effective: 2024-02-01
Filed: January 18, 2024, 6:59 PM ET

appointed Michael Sardano (“Mr. Sardano”) as a director, effective February 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Sardano was appointed as Director at Sensus Healthcare, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Michael Sardano (“Mr. Sardano”) as a director, effective February 1, 2024.

View on SEC.gov

Sensus Healthcare, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-004491

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.